Chemokines and leukocyte traffic

2.3k indexed citations
published 1998
Journal
Nature

In The Last Decade

doi.org/10.1038/33340 →

Countries where authors are citing Chemokines and leukocyte traffic

Specialization
Citations

This map shows the geographic impact of Chemokines and leukocyte traffic. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chemokines and leukocyte traffic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chemokines and leukocyte traffic more than expected).

Fields of papers citing Chemokines and leukocyte traffic

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Chemokines and leukocyte traffic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Chemokines and leukocyte traffic.

About Chemokines and leukocyte traffic

This paper, published in 1998, received 2.3k indexed citations . Written by Marco Baggiolini covering the research area of Oncology and Immunology. It is primarily cited by scholars working on Immunology (1.5k citations), Oncology (1.4k citations) and Molecular Biology (347 citations). Published in Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/33340.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026